Skip to content
  • Sunday, 26 July 2026
  • 1:44 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Laboratory Automation & Robotics

Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s

Lana Keisha Jul 25, 2026 0

A new paradigm in therapeutic development is emerging as Remepy, a pioneering startup, successfully completed a Phase IIa clinical trial…

Read More
Laboratory Automation & Robotics

Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s

Lana Keisha Jul 10, 2026 0

A new era in therapeutic innovation is dawning, marked by the successful Phase IIa clinical trial results for Hybridopa, an…

Read More
Biotech & Genetic Research

A New DNA Test for Soil Unlocks Critical Insights into Plant Biomass, Carbon Storage, and Climate Resilience

Jia Lissa Jul 10, 2026 0

A groundbreaking droplet digital PCR (ddPCR) method, developed by researchers at Aarhus University in Denmark, is poised to revolutionize our…

Read More
Biotech & Genetic Research

A Novel DNA Test Revolutionizes Root Biomass Quantification and Unlocks Deeper Insights into Plant Carbon Storage

Jia Lissa Jul 2, 2026 0

A groundbreaking new droplet digital PCR (ddPCR) method, developed by researchers at Aarhus University in Denmark, is poised to transform…

Read More
Laboratory Automation & Robotics

Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s

Lana Keisha Jun 29, 2026 0

In a significant advancement for integrated medicine, Remepy, a pioneering startup, has announced successful Phase IIa clinical trial results for…

Read More
Laboratory Automation & Robotics

Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s.

Lana Keisha Jun 22, 2026 0

A significant stride in the realm of integrated medicine has been reported by Remepy, a pioneering startup, as its innovative…

Read More
Laboratory Automation & Robotics

Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s

Lana Keisha Jun 15, 2026 0

In a significant advancement for integrated medicine, Remepy, a pioneering startup, has announced successful Phase IIa clinical trial results for…

Read More
Neuroscience & Brain Research

Artificial Intelligence Struggles with Cognitive Control as Leading Models Falter in Classic Stroop Test Experiments

Rifan Muazin Jun 15, 2026 0

The rapid evolution of artificial intelligence has led to the development of systems capable of passing bar exams, diagnosing rare…

Read More
Environmental & Analytical Chemistry

A Revolutionary Tongue Swab Test Promises to Transform Tuberculosis Diagnosis, Offering Hope to Millions

Abdurrohim Arsyad May 29, 2026 0

The global fight against tuberculosis (TB), the world’s deadliest infectious disease, may be on the cusp of a significant breakthrough…

Read More
Molecular & Cell Biology

Mezcal worm in a bottle DNA test reveals a surprise

Angie Faith Apr 26, 2026 0

At the bottom of some mezcal bottles sits one of the most recognizable curiosities in the world of spirits: a…

Read More

Posts pagination

1 2
Molecular Catapults and Quantum Speed: How Cambridge Researchers Redefined Electron Transfer in Solar Energy HarvestingTWiV 1291: A foot in the door for cytomegalovirusUnlocking Cellular Highways: Oregon Researchers Discover Internal "Trade Winds" Revolutionizing Understanding of Cell Movement and DiseaseBacteria Exhibit Astonishing Mobility Beyond Flagella, Revealing New Strategies for Spread and Infection
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ